Listed with other top experts in: 

In addition, she has also served as expert advisory services, market analysis and research for investment firms and companies developing HPV and other women's health diagnostic offerings, particularly in vitro diagnostics.

2007 to

(Undisclosed Consulting Company)

President

In this capacity, Expert provides business strategy, product development and marketing, technology valuation, and market research and analysis services with focus on the healthcare industry.

2006 to 2006

Digene

HPV Market Manager

As a marketing manager for the US HPV market, Expert was responsible for creating and executing a marketing plan and budget of $550K annually. She achieved sales growth of 30% each quarter.

2004 to 2005

Immersion Medical

Senior Product Manager

2003 to 2004

Stryker Orthopaedics

Product Manager

Expert managed marketing of Simplex® Bone Cement (market leader with 80% share) and related new product development; provided business analysis, training and support to over 600 sales reps. Equipped reps with competitive knowledge and clinical information to target surgeons and hospital administrators. She grew Simplex sales 26% in 2003.

2001 to 2003

Partners Healthcare System

Marketing/Business Development Manager, Worldwide Marketing

Managed academic/industry relations to facilitate exchange and commercialization of intellectual property assets. Evaluated and marketed pre-clinical intellectual property (IP) to industry in areas such as cardiovascular, oncology, orthopaedics, molecular diagnostics and transplant. Established relationships with pharmaceutical/biotech and medical device companies worldwide.

2000 to 2001

Emergence Consulting

Consultant

Provided consulting services to clients in various industries, such as telecommunications, manufacturing, energy, travel and leisure and industrial markets. Conducted extensive primary and secondary research. Contributed to success of business development efforts.

1998 to 2000

Agilent Technologies/Hewlett Packard

Senior Financial Analyst

Supported a $660M Patient Monitoring Division and $35M Point-of-Care Division. Responsibilities included acquisition target investigation and analysis, product pricing and costing resulting in awareness of ROI/NPV/profitability across product development teams and lower COGS. Other responsibilities were month-end close, variance analyses, financial budgeting and strategic forecasting, product generation process support and ad hoc analyses.

• • Multi-phase due diligence, financial modeling and business model development project to identify new suppliers and model a new, oral contraceptive sourcing entity for a major public health organization. Recommendations for partners and business model were accepted by senior management and are being implemented.• Identify foreign IUD suppliers for the US public health market. Develop business and financial models for new self-sustaining entity serving public health clinics that is funded by a large philanthropic organization.• Strategy development of an NGO focused on international women's reproductive health. Develop financial and business models for a self-sustaining entity serving international public health.
• • Expert advisory services, market analysis and research for investment firms and companies developing HPV and other women's health diagnostic offerings.
• • Branding strategy development and market research for a regional clinical laboratory with HPV offering.• Strategy development and market analysis for a technology company utilizing homegrown phage technology to penetrate the food industry.
• • Technology assessment and new product market opportunity sizing for a blood storage company.
• • Organizational efficiency assessment, process standardization with recommendations for an entertainment company.